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Class II (Ia) molecules are polymorphic integral membrane proteins that, in as-
sociation with processed antigen, comprise the ligand complex bound by antigen
receptors (TCR) on CD4+ T lymphocytes. The association of this ligand with the
TCR on T helper lymphocytes initiates the activation program that is a requisite
event for thepromotion ofbothhumoral andcell-mediated immuneresponses. During
the past several years much has been learned about the sequences ofclass II mole-
cules, peptideantigens, and TCRs. Hypothetical models ofthe class II three-dimen-
sional molecular structure have also been proposed, based on the solution to the
class I crystal structure (1). Although direct binding analyses indicate that a TCR
ligand isformed when classII molecules bind toprocessedantigen(2, 3), only limited
information is available concerning the molecular interactions that occur when a
class II molecule associates with a peptide antigen and a TCR.
Class II molecules are glycoproteins that consist of a 34-kD a polypeptide non-
covalently associated with a 29-kDa polypeptide. These two polypeptides associate
to form amolecule containing two extracellular domains on the plasma membrane
ofa variety ofdifferent cell types. Sequence analysis ofthe a and 0 genes has shown
that the polymorphic residues tend to be clustered in three or four regions of the
polypeptides that comprise the membrane-distal domain (designated al(31) (4-6).
Since all ofthe antibody and TCR binding sites analyzed have been mapped to the
membrane-distal domain (7-9), the polymorphic residues in the a.101 domain are
involved in determiningthe allele-specific antibody binding sites as well as informing
the TCR ligand.
To identify the a chain polymorphic residues that are involved in determining
epitopes recognized by antibodies and by the TCR we have constructed A0 genes
containing mutations that result in one or more d allele residue substitutions in the
/31 domain. The mutant A0 polypeptides were expressed in association with either
the wild-type Ak or Ad polypeptides after transfection of the genes into the B lym-
phoma cell line M12.C3 (9). In a previous report, we used thispanel ofcells bearing
the mutant class II molecules to identify the polymorphic residues that determine
the immunodominant serologic epitope on both the Ak and Ad polypeptides (9).
In this report the class II mutants were tested for their ability to stimulate a panel
ofAk or Ad alloreactive T hybridomas in order to identify the k and d polymorphic
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residues in the 01 domain that determine either the loss or the gain of epitopes rec-
ognized by these alloreactive TCRs. Our results demonstrate that both antibody
and TCR binding sites can be comprised of the same 0 chain polymorphic residues.
However, the majority ofthe TCR binding sites identified with this panel ofalloreactive
T cell hybridomas map to polymorphic residues that are predicted to be located
at the bottom of the putative antigen binding site on the class II molecule.
Materials and Methods
Cell Lines.
￿
The panel of wild-type or mutant class II-bearing cloned cell lines was pre-
pared by transfecting into MUM B lymphoma cells, plasmids containing the wild-type Ak
or mutant Ap(designated-AS') genes, the neomycin resistance gene pRSVneo, and in certain
cases, with the wild-type Ak gene. A detailed description of the methods used to construct
the A,3 genes and to transfect the genes into MUM cells is given elsewhere (9). Cloned
lines bearing class II molecules were selected by quantitative immunofluorescence for com-
parable levels of class II antigen expression. Nomenclature: As* and Aa transfected M12 .C3
cells are designated TN, with N indicating the position(s) or polymorphic region(s) sub-
stituted in the As" /31 domain with d-allele residues. Cells expressing Ak* Ad molecules are
designated TN-Ad and cells expressing wild-type A« polypeptide associated with an A~ poly-
peptide containing d allele residues throughout the (31 domain are designated TApk Aa. The
transfected cells were cultured in RPMI 1640 medium (Gibco Laboratories, Grand Island,
NY), 1 MM L-glutamine, 0.1 mM 2-ME, 10 mM Hepes, and 600 ftg/ml G418.
T CellAssays.
￿
T hybridomas 59.16, 22.1, and 98.11 were produced by fusing BW5147 cells
with lymph node cells from DBA/2 mice that had been primed in vivo with TAk cells
(M12.C3 cells expressing wild-type Ak and Ak genes). T hybridoma DG11 is a CBA/J anti-
BALB/c origin and hybridoma DIG10 is a C57BL/6 anti-BALB/c origin. Both hybridomas
are Ad-reactive (10). IC4 is an Ad-autoreactive T cell hybrid (10). The Ad-reactive T hybrids
were generously provided by Dr. Robert Chesnut (National Jewish Hospital, Denver, CO).
To assay for T hybridoma activity, 105 T hybridoma cells were cocultured with varying
numbers of wild-type or mutant class II-bearing MUM cells or with mock-transfected
(TNEO) cells. After 24 h of culture, supernatants were collected and assayed for IL-2 con-
tent in a secondary culture by using HT-2 cells as previously described (11). HT-2 cells
(104/well) were cultured for 24 h with serial dilutions of T hybridoma culture supernatants,
and the degree of stimulation was measured by the incorporation of [3H]thymidine into DNA
during the final 6 h of the culture period. Results shown in the figures are representative
experimental values of [3H]thymidine incorporation obtained from HT-2 cells cultured with
T hybridoma supernatants diluted 1/64.
Results
The Ak and Ad class II proteins differ significantly in both their allospecific sero-
logic epitopes and TCR binding sites. To identify which of the 14 (31 domain posi-
tions that differ between the k and d alleles are responsible for determining the allo-
specificities, we have produced a panel of cloned cell lines, each of which expresses
a mutant Ak (Ak*) polypeptide (containing one or more d allele residues in the /31
domain) associated with either a wild-type Ak n polypeptide or a wild-type Ad poly-
peptide (see Fig. 1 for a description of the Ak* mutants).
Loss ofk Allele Specicities.
￿
The mutant class II-bearing cells were tested for the
capacity to stimulate IL-2 secretion from three different Ak-reactive (Ad-nonreac-
tive) T cell hybridomas. Representative experiments illustrating the effects of muta-
tions in different regions of the (31 domain are shown in Fig. 2, while the complete
set of variants tested is summarized in Table I. Two of the T hybridomas, 22.1 andk
￿
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FIGURE 1.
￿
Amino acid sequences of the Ak and Ad R-1 domains (4). Mutant AQ* genes encoding
d-allele residues at each of the 14 polymorphic positions, at multiple positions, or in polymorphic
regions oftheal domain have been constructed by site-directed mutagenesis (9). The boundaries
and designation chosen for these polymorphic regions are indicated below the sequences.
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FIGURE 2. Representative activation re-
sponses of Ak alloreactive T hybridomas
stimulated with transfected M12.C3 cells. (A)
A'-reactive T hybridoma 22.1 stimulated
with M12.C3 cells expressing wild-type Ak ~Ak
molecules (TAO A~, A0*A~ molecules con-
taining d-allele residues at position 9 (T.9), or
in regions "B", "C", and "D" (TBCD) in the
/3 chain. M12.C3 cells expressing Ak*A~ mol-
ecules containing d residues at either position
12, 13, 14, or 17 in the 0 chain elicited re-
sponses identical to mock-transfected, la-
cells (T.Neo) (data not shown). (B) Ak-
reactive T hybridoma 59.16 stimulated with
M12.C3 cells expressing wild-type Ak Ak
molecules (TAk A~, Ak o" Aa molecules con-
taining d-allele residues in the /31 regions "B",
"C", and "D" (T.BCD), or at position 9 or 17,
or mock-transfected, Ia cells (TNeo). (C),
Ak-reactive T hybridoma 98.11 stimulated
with M12.C3 cells expressing wild-type Af A~ k
molecules (TA0k Ak n), wild-type Ak Ad mole-
cules (TA0 A«), A13` A«molecules containing
d allele residues in the /31 region A (TA-A«),
or mock-transfected, Ia cells (TNeo).1648
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59.16, are activated by cells expressing the wild-type AR A« molecule (TAO A,), but
not by cells expressing the wild-type hybrid AR Ad molecule (TAO A«) (Fig. 2, A
and B; Table I). In contrast, the third T hybridoma, 98.11, is activated equally well
by cells expressing either wild-type AO Aa or AO Ad molecules (Fig. 2 C). None of
the T hybridomas are activated by the Ia", mock-transfected MUM cells (TNeo)
or by cells expressing an la molecule consisting of a AO* polypeptide containing
d allele sequence throughout the entire (31 domain associated with a wild-type A',
polypeptide (TAak Adl). These results indicate that the antigen receptors on the T
hybridomas 22 .1 and 59.16 recognize some combination of k allele polymorphic
residues in both the /31 domain and in the A« polypeptide. In contrast, the antigen
receptors on the T hybridoma 98.11 recognize k allele polymorphic residues in the
/31 domain but do not discriminate A« from Aa polymorphic residues .
When these three Ak-reactive T cell hybridomas were assayed for their response
to the mutant class II molecules, the response of the T hybridomas 22_1 and 59.16
to the class II mutant that contains d allele residues in the entire COOH-terminal
half of the (31 domain (TBCD) was greater than the response to wild-type AO Aa
molecules. Since TBCD cells do not expresshigher levels of class II molecules than
wild-type TAO Aa cells (9), the observed response likely results from the TCRs on
these two T hybridomas binding with higher affinity to the class II ligand complex
on TBCD cells than on T.AO Aa cells (Fig. 2, A and B; Table I). Both T hybrid-
omas also reacted to AO* mutants containing single d allele residues at either posi-
tion 28 or 40 (T28, T40). These results indirectly suggest that the antigen receptors
on both T cell clones recognize /3 chain polymorphic residues in region "A" (residues
9-17). We cannot assess directly if the TA AO* Aa molecule will stimulate these two
T hybridomas because the mutant AO* polypeptide containing d allele residues in
region "A" cannot be expressed in association with the Ak molecule (12). However,
we were able to map the epitope recognized by these two T hybridomas by assaying
cells expressing the wild-type Ak polypeptide with an AO* polypeptide containing
a single dallele substitution at either position 9, 12, 13, 14, or 17 . As shown in Fig.
2, A and B, and Table I, T hybridoma 59 .16 responds to mutants T.9 and T.17 but
not to mutants T12, T13, or T14, while T hybridoma 22.1 is not stimulated by any
of these five single residue mutants. Together these analyses map the epitopes recog-
nized by these T cell receptors to an overlapping set of polymorphic residues in re-
gion "A" of the (31 domain.
In contrast, T hybridoma 98.11, which fails to discriminate Ac', from Aa polypep-
tides, responds to the cell line expressing the AO* A« molecule containing d allele
residues in region "A" (TA-A«) (Fig. 2 C). When the /3 chain mutants with dsubsti-
tutions in either region "B", "C", "D", or combinations of these polymorphic regions
were assayed, none stimulated the 98.11 T cells. Thus, although the epitopes recog-
nized by T hybridomas 59.16 and 22 .1 map to a limited number of k allele poly-
morphicresidues (12, 13, 14 or 9, 12, 13, 14, 17, respectively), theThybridoma98.11
appears to recognize acomplex epitopedetermined by k allele polymorphic residues
in regions "B", "C", and "D".
Gain ofdAllele Specicities.
￿
Although TCRepitopes canbe mapped by measuring
the inability of certain 0 chain mutants to initiate T cell activation, results from
such analyses must be interpreted with caution. The introduction of certain amino
acids into the class 11 polypeptides may result in an alteration of the conformationt
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of spatially distant residues. Such conformational alterations are difficult to detect
and could result in the misidentification of the polymorphic residues that comprise
the TCR contact points. An alternative to measuring the loss of allospecificities in
the panel of mutant AQ* stimulator cells is to assay for the gain of new d al-
lospecificities after the introduction of a limited number of dallele residues into the
Ap polypeptide sequence. It is more likely that the gain of an Ad-specific epitope
will be due directly to the structural alterations introduced by the dallele polymorphic
residues.
When three different Ad reactive T hybridomas were tested with the panel of mu-
tants, each of the T cells was activated by the stimulator cells expressing wild-type
Ad d and an Ak* molecule containing d allele residues throughout the 01 domain
(TAak Ad d) (Fig. 3 ; Table I). Cells expressing Neo, wild-type AO Act, or wild-type
Aa A« molecules failed to stimulate these T cells. These results suggest that the an-
tigen receptors on these T hybridomas recognize d allele polymorphic residues in
the /31 domain. Since the Ag polypeptide fails to associate with the Aa polypeptide
(7), possible contributions of the a polymorphic residues to the T cell epitopes were
assessed from mutant A0* polypeptides that can associate with Aa.
When the three T hybridomas were assayed with the /3 chain mutants, each ex-
hibited a distinct reactivity pattern. As shown in Fig. 3 A, clone DG11 is stimulated
by class II molecules comprised of a wild-type A« (or Ad,,) polypeptide and an Aa*
polypeptide containing three d allele residues at positions 65-67 (T65-67 or T65-
67-Aa). As summarized in Table I, the DG11 cells are also stimulated by any other
a chain mutant into which these three d residues have been substituted (TB, TB-
Ad, TABC-Ad d, T.BCD, TBCD-Ad d, TAB-Ad,). Residues 65-67 have been identified
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FIGURE 3. Representative activation re-
sponses of Ad alloreactive T hybrrdomms
stimulated with transfected M12.C3 cells. (A)
Ad-reactive T hybridoma DG11 stimulated
o-o rn° p"nQ
￿
with M12.C3 cells expressing wild-type Ak SA«
0-0 rrkna
￿
molecules (TAQ A~, wild-type Ad polypep-
o-o r.e
￿
tides associated with AS` polypeptides con
A-A r.s3
￿
taining d-allele residues either throughout the
/31 domain (T.A01kAa), or wild-type Akk poly-
0-0 r.ss-s7
￿
peptides associated with A0~ polyp"
containing d residues in either region "B"
3x103 ￿10 4 ￿300 4 ￿(TB), at position 63, (T63) or at position 65,
STIMULATOR CELLS
￿
66, and 67 (T65-67). M12.C3 cells transfected
only with pRSVneo(Tneo) elicited a response
identical to that obtained with TAg Aucells.
(B) Ad-reactive T hybridoma IC4.4 stimu-
lated with M12.C3 cells expressin, wild-type
A" polypeptide associated with AS* polypep-
tides containing d allele residues throughout
the /31 domain (T.A#1k Ad .), in regions "A' and
"D" (TAD-Ag) or in regions "t1, "C", and "D"
(TACD-Aa). Mock-transfected, la- M12.C3
cells (TNeo) elicited a response comparable
to cells expressing a wild-type Ad polypeptide
associated with a A0 polypeptide containing
3x10 3 ￿10 4 ￿300 4
￿
d allele residues in either region "A' (TA-Add n)
STIMULATOR CELLS
￿
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in previous experiments as being directly responsible for determining the loss of
Ak specific serologic epitopes and the gain of Ad-specific serologic epitopes (9).
Thus, the DG11 antigen receptor recognizes an epitope composed of, in part, the
same polymorphic residues that comprise the immunodominant R chain serologic
epitope. In addition, both the antibodies that react with the epitope comprised of
residues 65-67 and the DGll TCR recognize the T65-67, TB, and TBCD AO*
polypeptides associated with either the Akk or the Ad d polypeptide (Table I). These
results demonstratethat neithertheseserologic epitopes nor the DG11 TCRepitope
is affected by the substitution of k or d a chain polymorphic residues.
The hybridoma IC4 is reactive to Ia molecules composed of a wild-type Add poly_
peptide and a Ak* polypeptide containing d allele residues in both regions "A" and
"D" (TAD-Ad d, TACD-Aa) (Fig. 3, B; Table I). Since neither TA AO* A« molecules
nor TD Aa* A« molecules activate IC4, the IC4 antigen receptor appears to recog-
nize a complex epitope composed of polymorphic residues in these two regions that
are widely separated in the primary sequence. As will be discussed later, these poly-
morphic residues are also predicted to be widely separated in the molecule's three-
dimensional structure (1).
Although the panel ofclass II mutants has enabled us to map thea chainlocation
of the epitopes recognized by receptors on five of the six T hybridomas, we have
been unsuccessful at identifying any mutant Ak* molecule, other than TAsk Ad dthat
will stimulate the T hybridoma DlG10 (Table I). The antigen receptor on this T
hybridoma may recognize a complex epitope containing a large number of d allele
polymorphic residues in the (31 domain (as expressed by T.A~k Ad or combinations
of d allele residues not represented in our panel of /3 chain mutants. For example,
an epitope composed ofdresidues at both positions 40 and 63 wouldnot be identified
in this analysis. A serologic epitope containing thesetwo residues hasbeen identified
previously in the analysis of the Aa-reactive mAb Y-212 (9).
Discussion
Brownet al. (1)have recently proposed ahypothetical modelofthethree-dimensional
conformation ofthe class II a1M domain based on the crystal structure ofthe HLA
A2 molecule. In this model, the polymorphic positions that we have identified as
contributing to the TCR binding sites are predicted to be located in distinct areas
of the class II molecule. The polymorphic residues in region "B", which are recog-
nized by the Ad-reactive T hybridoma, DG11, as well as by several Ad- or A'-reactive
mAbs, are predicted to be located in a turn between two a-helices that comprise
two sides of the putative antigen binding site. The side chains of these polymorphic
residues should be exposed to the aqueous environment on the exterior of the class
II molecule. Secondary structure predications suggest that region "D" is located in
aturn at the end of an a-helix (comprised, in part, of"C"region residues) that forms
one side of the putative antigen binding site. Thus, the 98.11 TCR epitope, which
maps to regions B, C, and D, is predicted to be located on one side wall of the puta-
tive antigen binding site. In contrast, region "A", which has been identified as com-
prisingpart ofthe TCR epitope forthree ofthe six Thybridomas assayed, is predicted
to be located in a (3-pleated sheetthat forms the bottom of theputative antigen binding
site. Together these results indicate that the TCR epitopes map to anumber ofresidues
that may be located in distinct regions in the 01 domain.1652
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Results from anumberofdifferent studieshaveindicated that TCRsbind to regions
onclass II molecules that are distinct from the regions bound by mAbs (13-15). The
results presented here demonstrate that at least four of the six T hybridomas tested
recognize regions on the ß chain that are distinct from the serologically im-
munodominant region that maps to residues 63-67. However, the antigen receptor
on one T hybridoma, DGII, appears to recognize the polymorphic residues 65-67.
Although we cannot determine from these analyses if the same nonpolymorphic
residues comprise both TCR and serologic epitopes, it is apparent that both types
of molecules are capable of binding to similar regions on the class II molecule.
It has been suggested previously that, unlike serologic epitopes, the ligand recog-
nized by most Th cells requires contributions ofpolymorphic residues in both the
a and ß chains (8). Results obtained in this study are consistent with this observa-
tion inthatfour ofthesixalloreactiveT hybridomas tested recognizeepitopes deter-
mined by polymorphic residues in both polypeptides. Antigen-reactive TCR com-
bining sites may interact with residues from both polypeptides because it is these
residues in the a1ß1 domain that comprise or are adjacent to the putative antigen
bindingsite. It is unlikely that thelocation ofserologic epitopes onclass II molecules
is similarly constrained. It is interesting to note that the DG11 TCR binding site,
which is comprised ofthe same ßl domain polymorphic residues shown previously
to comprise part of the immunodominant serologic epitope, is similar to the ß
chain-specific serologicepitopes in that theTCR reacts with class II molecules con-
sisting ofeither Ad dor Akk polypeptides. Although the similarity in the Ab and TCR
epitopes may be fortuitous, it may reflect a fundamental difference between the na-
ture ofsome allospecific T cell determinants and determinants that are comprised
of processed antigen and self class 11 molecules.
The data presented inthis report clearly identify thepolymorphicresidues respon-
sible for the activation ofseveral Ak- and Ad-specific T hybridomas. These residues
may be the contact points that mediateTCRbinding. However, it has been hypothe-
sizedthat theligand recognized byalloreactiveTCRs is a composite offoreign class
II residues and residues ofaprocessed peptidelocated in theclass II antigen binding
site (16, 17). Ifthis hypothesis is correct, we may have identified residues that are
actually contact points foraprocessed polypeptide, which may be theprincipal ligand
boundby the alloreactive T cell hybridoma receptors. However, both types ofligands
could be represented in this analysis. For example, TCRs that map to region "A"
may recognize ligands that are composed of some combination of residues from a
processed peptide and the class II molecule, while TCRs that map to polymorphic
residues that also comprise the serologically immunodominant site (region"B")may
recognize ligands made up ofonly class II residues. Direct experimental evidence
for either type of allo-reactive T cell ligand is lacking. The panel of Ia mutants and
T hybridomas described in this report provides a defined model system with which
to experimentally evaluate this problem.
Summary
In an effort to characterize the ligand that is bound by T helper lymphocyte an-
tigen receptors, we have begun to identify class II polymorphic residues that com-
prise part ofthe allospecific TCR binding sites. Site-directed mutagenesis was used
to construct mutant Aá (Aß*) genes that encode polypeptides into which single orBUERSTEDDE ET AL.
￿
1653
multiple residues of the Ad polypeptide have been substituted in the 01 domain. A
panel of cloned cell lines expressing the mutant AO* A« or AO* A« molecules was
analyzed for the ability to stimulate Ak or Ad alloreactive T cell hybridomas. Sub-
stitution of d for k residues at specific positions in the 01 domain resulted not only
in the loss of epitopes recognized by Ak-reactive T cells but, more importantly, in
the gain of epitopes recognized by Ad-reactive T cells. Some of the polymorphic
residues identified as contributing to the T cell epitopes are the same residues that
contribute to the serologically immunodominant epitope. Other T cell epitopes map
to positions predicted to be located either in an cz-helix forming one side, or in a
,6-pleated sheet forming the bottom of the putative antigen binding site. Thus, un-
like serologic epitopes, TCR epitopes can be determined by A0 polymorphic residues
in many different regions of the /31 domain and frequently depend upon contribu-
tions of A« polymorphic residues.
We thank Dr. Robert Abraham for providing us with HT2 cells, Theresa Lee for expert prep-
aration of the manuscript, and Dr. Jerry Brown for helpful discussions.
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